Univentricular Palliations: New Hope for Congenital Heart Patients?
"Heart transplantation offers a solution for children with complex congenital heart defects that require univentricular palliation, but it comes with significant challenges."
Congenital heart defects (CHDs) are structural abnormalities present at birth, affecting the heart's normal function. In severe cases, where a child is born with a single functional ventricle (univentricular heart), a series of palliative surgeries known as univentricular palliation are performed. These procedures, such as the Fontan procedure, aim to improve blood flow and oxygenation but are not curative.
While univentricular palliation can extend a child's life and improve their quality of life, it is associated with long-term complications, including heart failure, liver dysfunction, and protein-losing enteropathy. In some cases, heart transplantation becomes the only viable option for survival.
Orthotopic heart transplantation, where a diseased heart is replaced with a healthy donor heart, presents a unique set of challenges in patients who have undergone previous univentricular palliation. The altered anatomy and prior surgeries complicate the transplantation procedure and require specialized expertise.
Heart Transplantation After Univentricular Palliation: Addressing the Challenges
A study published in the Journal of Cardiothoracic Surgery in 2015 investigated the outcomes of orthotopic heart transplantation in patients who had previously undergone univentricular palliation. The study, led by María-Teresa González-López and colleagues, reviewed the surgical techniques and results in a cohort of 23 congenital cardiac patients who underwent heart transplantation between 2013 and 2014.
- Surgical Techniques: The researchers employed various surgical techniques to address the challenges posed by the altered anatomy and prior surgeries. These included hemiarch repair, pulmonary artery (PA) branches plasty, hilum-to-hilum PA reconstruction, superior venae cavae reconstruction, stent removal from PA, and inferior venae cavae reconstruction.
- Outcomes: The average cardiopulmonary-bypass time was 257.6 minutes, and the average total-ischemia-time was 220.7 minutes. One patient required ECMO (extracorporeal membrane oxygenation), a life-support machine that oxygenates the blood outside of the body. Four patients underwent delayed sternal closure, and two patients underwent diaphragm plication, a surgical procedure to correct diaphragmatic paralysis. One patient experienced subacute-humoral-rejection, a type of immune response that can damage the transplanted heart, and was treated with plasmapheresis, a procedure to remove antibodies from the blood. The in-hospital stay averaged 44 days.
- Follow-Up: At a follow-up of 14.4 months, the freedom from percutaneous procedures, such as angioplasty or stenting, was 83.3%. There was no 30-day mortality or follow-up mortality. All patients remained with an optimal functional class, indicating that they were able to perform their daily activities without significant limitations.
Hope and the Future
Heart transplantation following univentricular palliation offers hope for children with complex congenital heart defects. While the procedure is technically challenging, advancements in surgical techniques and immunosuppression have improved outcomes. Further research and long-term follow-up are needed to optimize the management of these patients and ensure the best possible quality of life.